Regentis Biomaterials Ltd.
RGNT- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001912966
No open-market purchases or sales by Regentis Biomaterials Ltd. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $2.98M in total; no superinvestor holds it.
Superinvestors holding RGNT, Q2 2026
No superinvestor reported holding RGNT in Q2 2026.